Related Experiment Video

Updated: Sep 21, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 3, 2007

[Demyelinating elements of demyelinated encephalopathy]

J Yuan1

  • 1Department of Neurology, First Hospital, Beijing Medical University.

Zhonghua Shen Jing Jing Shen Ke Za Zhi = Chinese Journal of Neurology and Psychiatry
|October 1, 1991
PubMed

Insights

Researchers investigated W1 protein levels in demyelinating encephalopathies. Two types were identified: one with altered W1 protein and another with normal levels despite demyelination, suggesting different disease causes.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Context:

  • Demyelinating encephalopathies are characterized by myelin damage.
  • Myelin basic protein is a known encephalitogenic antigen.
  • The role of other myelin components, like W1 protein, is less understood.

Purpose:

  • To investigate the relationship between W1 protein and demyelinating encephalopathies.
  • To differentiate types of demyelinating encephalopathies based on W1 protein levels.

Summary:

  • Immunocytochemical analysis using a 2',3'-cyclic nucleotide 3'-phospho-diesterase (CNPase) antibody was performed on brain samples from 5 demyelinating encephalopathies and 2 normal controls.
  • Two distinct patterns of W1 protein expression were observed in relation to demyelination.
  • Type 1 showed W1 protein levels paralleling demyelination, while Type 2 exhibited normal W1 protein levels despite demyelination.
  • Type 1 included multiple system degeneration, Binswanger's disease, and postvaccinal encephalopathy (type B encephalitis).
  • Type 2 included multiple sclerosis and Balo's concentric sclerosis.

Impact:

  • These findings suggest distinct pathogenetic mechanisms underlying different forms of demyelinating encephalopathies.
  • The study provides a basis for further research into the specific roles of W1 protein in neurological disorders.
  • Classification into Type 1 and Type 2 may aid in diagnosis and treatment strategies for demyelinating diseases.

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis08:17

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...